News & Analysis on Clinical Trial Services & Contract Research And Development
WHO recently assessed Biopharma Services, which demonstrated compliance across multiple regulatory and organizational guidelines – opening the doors to conduct more work with the WHO foundations.
Fusion Antibodies signed an agreement with Analytics Engines to bring machine learning and AI to its humanization platform in an aim to bolster product quality and manufacturability.
Sygnature Discovery is opening its first office in the US – the CRO’s largest market and one in which it sees the biggest growth potential, says CEO.
UK government and ABPI have agreed a deal to limit branded drug sales growth to 2%, potentially reducing the cost of medicine by £930m.
Sun Pharma has announced plans to acquire Pola Pharma for $1m, adding topical drug and injectables manufacturing capabilities to its network in Japan.
Fresenius Kabi voluntarily recalled 163 lots of sodium chloride injections, after the presence of latex was found within its packaging.
Exclusive interview
QPS has expanded its Phase I clinical trial capabilities by more than 20% and doubled its lab space, which will allow the CRO to accommodate ‘exponentially more sponsors’ as demand continues to increase.